Literature DB >> 7515062

Dephosphorylation of insulin receptor substrate 1 by the tyrosine phosphatase PTP2C.

M R Kuhné1, Z Zhao, J Rowles, B E Lavan, S H Shen, E H Fischer, G E Lienhard.   

Abstract

The phosphotyrosine (Tyr(P)) form of insulin receptor substrate 1 (IRS-1) is a key component in insulin signaling. Our previous study revealed that Tyr(P) IRS-1 binds to the widely distributed tyrosine phosphatase PTP2C through the src homology 2 (SH2) domains of the latter. In the present study, we examined the activity of this enzyme and of a truncated form lacking the SH2 domains (delta PTP2C) toward IRS-1 and also toward the cytoplasmic domain of the insulin receptor. Tyr(P) IRS-1 was prepared by phosphorylation of recombinant IRS-1 with recombinant cytoplasmic insulin receptor kinase (CIRK). PTP2C rapidly dephosphorylated Tyr(P) IRS-1; dephosphorylation by delta PTP2C was approximately one-third as fast. Other substrates, including Tyr(P) CIRK, were not dephosphorylated as rapidly by PTP2C; moreover, delta PTP2C was at least 10 times more active than PTP2C toward CIRK and other substrates. These results indicate that the binding of Tyr(P) residues on IRS-1 to the SH2 domain(s) of PTP2C enhances its activity toward IRS-1 and suggest that PTP2C is the phosphatase responsible for the dephosphorylation of IRS-1 in vivo. In addition, with the expectation that a PTP2C-resistant form of IRS-1 will be useful in investigations of IRS-1 function, we determined that IRS-1 can be thiophosphorylated with adenosine 5'-O-(3-thiotriphosphate) and CIRK and that this form of IRS-1 is resistant to PTP2C.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515062

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.

Authors:  S Tanaka; J R Wands
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 2.  Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases.

Authors:  B J Goldstein; F Ahmad; W Ding; P M Li; W R Zhang
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

Review 3.  Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling.

Authors:  I G Fantus; G Deragon; R Lai; S Tang
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

4.  Biochemical and morphological characterization of vascular and lymphocytic interleukin-4 receptors.

Authors:  B Schnyder; S M Lugli; S Schnyder-Candrian; V M Eng; R Moser; J Banchereau; B Ryffel; B D Car
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

5.  Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1.

Authors:  B Schnyder; H Lahm; G Woerly; N Odartchenko; B Ryffel; B D Car
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

6.  Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase.

Authors:  R Mèndez; M G Myers; M F White; R E Rhoads
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

7.  Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.

Authors:  F Ahmad; R V Considine; B J Goldstein
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 8.  Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance.

Authors:  Elaine Xu; Michael Schwab; André Marette
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

9.  Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling.

Authors:  K Yamauchi; K L Milarski; A R Saltiel; J E Pessin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

10.  Activation of phospholipase C gamma in Schizosaccharomyces pombe by coexpression of receptor or nonreceptor tyrosine kinases.

Authors:  S Arkinstall; M Payton; K Maundrell
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.